Health & Life Sciences Health & Life Sciences Addressing the Mental Health Crisis Among Predoctoral and Postdoctoral Researchers in STEM The federal government must ensure that success for early-career STEM professionals does not demand mental-health sacrifice. Health & Life Sciences Establishing a National Endemic Disease Surveillance Initiative (NEDSI) The Biden-Harris Administration should establish a National Endemic Disease Surveillance Initiative (NEDSI) to remove barriers to tracking and predicting endemic, infectious diseases. Health & Life Sciences Innovation & Economic Competitiveness Combating Bias in Medical Innovation The Biden-Harris Administration must act to address bias in medical technology at the development, testing and regulation, and market-deployment and evaluation phases. Health & Life Sciences Regulating Probiotic Use and Improving Veterinary Care to Bolster Honeybee Health The FDA and USDA should improve the administration of antibiotics in apiculture and strengthen the regulation of pre- and probiotic supplements marketed to commercial beekeepers. Health & Life Sciences Supercharging Biomedical Science at the National Institutes of Health NSF should rigorously evaluate its research funding mechanisms to foster scientific breakthroughs. Health & Life Sciences Eliminating Childhood Lead Poisoning Worldwide The United States should adopt a roadmap to help LMICs implement policies needed to achieve global elimination of childhood lead poisoning. Health & Life Sciences Innovation & Economic Competitiveness Creating Advanced Market Commitments and Prizes for Pandemic Preparedness The U.S. should invest in AMCs and prizes for vaccine development and deployment as part of the American Pandemic Preparedness Plan. Health & Life Sciences Innovation & Economic Competitiveness Curing Alzheimer’s by Investing in Aging Research Now is the time for the NIA to drive science-first funding for the field of aging. Health & Life Sciences National Security Maintaining Military Medical Readiness Today Saves Lives Tomorrow The White House should expand military-civilian partnerships in trauma care to achieve a national goal of eliminating preventable deaths. Health & Life Sciences Federal Approval of Over-the-Counter Birth-Control Pills The U.S. should approve over-the-counter (OTC) birth-control pills to ensure universal access to contraception. Health & Life Sciences Establish a $100M National Lab of Neurotechnology for Brain Moonshots Expand the BRAIN Initiative by investing in a National Laboratory of Neurotechnology to understand how the brain works at a deeper level. Health & Life Sciences Technology Policy Creating a National Infrastructure for Digital Mental Health Services Addressing the largely unregulated space of digital mental health products is critical to mitigate harm of unverified solutions. Health & Life Sciences Repurposing Generic Drugs to Combat Cancer Repurposing existing drugs, especially off-patent generics, is the fastest way to develop new cancer treatments. Health & Life Sciences Opening Up Mortality Data for Health Research Comprehensive and reliable mortality data will enable more effective response to rapidly evolving public health challenges. Health & Life Sciences Delivering Healthcare Services to the American Home Increasing the share of health services provided directly to patient homes is a significant opportunity to improve healthcare in the U.S. Health & Life Sciences A Federal Adaptive, On-Demand Pharmaceutical Manufacturing Initiative An investment of $5 billion over five years will improve U.S. pharmaceutical manufacturing infrastructure. Health & Life Sciences Rethinking Payment for Prevention in Healthcare The government should provide incentives to healthcare providers that scale up and reduce costs of delivering preventive interventions. Health & Life Sciences Elevating Patients as Partners in Management of Their Health Data and Tissue Samples The next administration should empower patients as partners in managing of their health data and tissue samples. Health & Life Sciences Providing High-Quality Telehealth Care for Veterans The Federal Government should build critical technology infrastructure that will facilitate expansion and use of telehealth for veterans. Health & Life Sciences An Evidence-based Approach to Controlling Drug Costs The next administration should control drug costs through an evidence-based approach to optimizing drug dosing and improving outcomes. Health & Life Sciences Innovation & Economic Competitiveness Advancing Economic, Health, and Racial Equity by Increasing the Use of Evidence and Data The next administration should ensure equitable recovery and economic mobility by promoting evidence-based decision-making across agencies. Health & Life Sciences Innovation & Economic Competitiveness A National Bioeconomy Manufacturing and Innovation Initiative A National Bioeconomy Manufacturing and Innovation Initiative would combat COVID-19, foster economic recovery, and address climate change. Health & Life Sciences A Draft Executive Order to Ensure Healthy Homes: Eliminating Lead and Other Housing Hazards Establish a cabinet-level Presidential Task Force on Lead Poisoning Prevention and Healthy Housing to eliminate lead poisoning. Health & Life Sciences Creating an Advanced Manufacturing Collaborative for PPE and Other Medical Device Supplies A proposal for the creation of a national collaborative to address PPE and medical device manufacturing in the United States. Energy, Environment & Climate Health & Life Sciences Preventing the Next Pandemics: An Upstream Approach to Novel National Security Threats A Federal strategy to monitor and mitigate the major factors that contribute to emerging infectious disease to eliminate future pandemics. Health & Life Sciences Building Medical Supply Chain Resilience through a U.S. Manufacturing Reserve and Digital Stockpile The Federal Government must create an emergency response plan to activate domestic, local medical supply manufacturing. Health & Life Sciences A National Strategy to Counter COVID-19 Misinformation The next administration should establish an office at the Dept. of Health and Human Services dedicated to combating COVID-19 misinformation. Energy, Environment & Climate Health & Life Sciences Improving Federal Management of Wildlife Movement and Emerging Infectious Disease The COVID-19 pandemic exposed systematic vulnerabilities in how wildlife movement and emerging infectious diseases should be managed. Health & Life Sciences Technology Policy Creating a COVID-19 Commission on Public Health Misinformation The next administration should create a high-level COVID-19 Commission on Public Health Misinformation. Health & Life Sciences Adopting an Open-Source Approach to Pharmaceutical Research and Development Address pharmaceutical market failures by launching a new program that takes an open-source approach to pharmaceutical R&D. Health & Life Sciences Transforming Infant Nutrition to Give Every Baby a Strong, Healthy Foundation A three-pronged approach to transform infant nutrition through the National Advisory Council on Maternal, Infant, and Fetal Nutrition. Health & Life Sciences Expanding the Health Policy Mission of the Veterans Health Administration A proposal to coordinate and consolidate the healthcare innovation, demonstration, and implementation capacities of the VA and HHS. Health & Life Sciences Building Trust In the Health Data Ecosystem A proposal to build trust in the health data ecosystem. Health & Life Sciences Addressing the Organ Donor Crisis Steps the federal government can take to end the organ transplant wait list. Health & Life Sciences Creating the Health Advanced Research Projects Agency (HARPA) The federal government can directly address the massive market failures at the center of our healthcare enterprise by establishing a new Health Advanced Research Projects Agency.
Health & Life Sciences Addressing the Mental Health Crisis Among Predoctoral and Postdoctoral Researchers in STEM The federal government must ensure that success for early-career STEM professionals does not demand mental-health sacrifice.
Health & Life Sciences Establishing a National Endemic Disease Surveillance Initiative (NEDSI) The Biden-Harris Administration should establish a National Endemic Disease Surveillance Initiative (NEDSI) to remove barriers to tracking and predicting endemic, infectious diseases.
Health & Life Sciences Innovation & Economic Competitiveness Combating Bias in Medical Innovation The Biden-Harris Administration must act to address bias in medical technology at the development, testing and regulation, and market-deployment and evaluation phases.
Health & Life Sciences Regulating Probiotic Use and Improving Veterinary Care to Bolster Honeybee Health The FDA and USDA should improve the administration of antibiotics in apiculture and strengthen the regulation of pre- and probiotic supplements marketed to commercial beekeepers.
Health & Life Sciences Supercharging Biomedical Science at the National Institutes of Health NSF should rigorously evaluate its research funding mechanisms to foster scientific breakthroughs.
Health & Life Sciences Eliminating Childhood Lead Poisoning Worldwide The United States should adopt a roadmap to help LMICs implement policies needed to achieve global elimination of childhood lead poisoning.
Health & Life Sciences Innovation & Economic Competitiveness Creating Advanced Market Commitments and Prizes for Pandemic Preparedness The U.S. should invest in AMCs and prizes for vaccine development and deployment as part of the American Pandemic Preparedness Plan.
Health & Life Sciences Innovation & Economic Competitiveness Curing Alzheimer’s by Investing in Aging Research Now is the time for the NIA to drive science-first funding for the field of aging.
Health & Life Sciences National Security Maintaining Military Medical Readiness Today Saves Lives Tomorrow The White House should expand military-civilian partnerships in trauma care to achieve a national goal of eliminating preventable deaths.
Health & Life Sciences Federal Approval of Over-the-Counter Birth-Control Pills The U.S. should approve over-the-counter (OTC) birth-control pills to ensure universal access to contraception.
Health & Life Sciences Establish a $100M National Lab of Neurotechnology for Brain Moonshots Expand the BRAIN Initiative by investing in a National Laboratory of Neurotechnology to understand how the brain works at a deeper level.
Health & Life Sciences Technology Policy Creating a National Infrastructure for Digital Mental Health Services Addressing the largely unregulated space of digital mental health products is critical to mitigate harm of unverified solutions.
Health & Life Sciences Repurposing Generic Drugs to Combat Cancer Repurposing existing drugs, especially off-patent generics, is the fastest way to develop new cancer treatments.
Health & Life Sciences Opening Up Mortality Data for Health Research Comprehensive and reliable mortality data will enable more effective response to rapidly evolving public health challenges.
Health & Life Sciences Delivering Healthcare Services to the American Home Increasing the share of health services provided directly to patient homes is a significant opportunity to improve healthcare in the U.S.
Health & Life Sciences A Federal Adaptive, On-Demand Pharmaceutical Manufacturing Initiative An investment of $5 billion over five years will improve U.S. pharmaceutical manufacturing infrastructure.
Health & Life Sciences Rethinking Payment for Prevention in Healthcare The government should provide incentives to healthcare providers that scale up and reduce costs of delivering preventive interventions.
Health & Life Sciences Elevating Patients as Partners in Management of Their Health Data and Tissue Samples The next administration should empower patients as partners in managing of their health data and tissue samples.
Health & Life Sciences Providing High-Quality Telehealth Care for Veterans The Federal Government should build critical technology infrastructure that will facilitate expansion and use of telehealth for veterans.
Health & Life Sciences An Evidence-based Approach to Controlling Drug Costs The next administration should control drug costs through an evidence-based approach to optimizing drug dosing and improving outcomes.
Health & Life Sciences Innovation & Economic Competitiveness Advancing Economic, Health, and Racial Equity by Increasing the Use of Evidence and Data The next administration should ensure equitable recovery and economic mobility by promoting evidence-based decision-making across agencies.
Health & Life Sciences Innovation & Economic Competitiveness A National Bioeconomy Manufacturing and Innovation Initiative A National Bioeconomy Manufacturing and Innovation Initiative would combat COVID-19, foster economic recovery, and address climate change.
Health & Life Sciences A Draft Executive Order to Ensure Healthy Homes: Eliminating Lead and Other Housing Hazards Establish a cabinet-level Presidential Task Force on Lead Poisoning Prevention and Healthy Housing to eliminate lead poisoning.
Health & Life Sciences Creating an Advanced Manufacturing Collaborative for PPE and Other Medical Device Supplies A proposal for the creation of a national collaborative to address PPE and medical device manufacturing in the United States.
Energy, Environment & Climate Health & Life Sciences Preventing the Next Pandemics: An Upstream Approach to Novel National Security Threats A Federal strategy to monitor and mitigate the major factors that contribute to emerging infectious disease to eliminate future pandemics.
Health & Life Sciences Building Medical Supply Chain Resilience through a U.S. Manufacturing Reserve and Digital Stockpile The Federal Government must create an emergency response plan to activate domestic, local medical supply manufacturing.
Health & Life Sciences A National Strategy to Counter COVID-19 Misinformation The next administration should establish an office at the Dept. of Health and Human Services dedicated to combating COVID-19 misinformation.
Energy, Environment & Climate Health & Life Sciences Improving Federal Management of Wildlife Movement and Emerging Infectious Disease The COVID-19 pandemic exposed systematic vulnerabilities in how wildlife movement and emerging infectious diseases should be managed.
Health & Life Sciences Technology Policy Creating a COVID-19 Commission on Public Health Misinformation The next administration should create a high-level COVID-19 Commission on Public Health Misinformation.
Health & Life Sciences Adopting an Open-Source Approach to Pharmaceutical Research and Development Address pharmaceutical market failures by launching a new program that takes an open-source approach to pharmaceutical R&D.
Health & Life Sciences Transforming Infant Nutrition to Give Every Baby a Strong, Healthy Foundation A three-pronged approach to transform infant nutrition through the National Advisory Council on Maternal, Infant, and Fetal Nutrition.
Health & Life Sciences Expanding the Health Policy Mission of the Veterans Health Administration A proposal to coordinate and consolidate the healthcare innovation, demonstration, and implementation capacities of the VA and HHS.
Health & Life Sciences Building Trust In the Health Data Ecosystem A proposal to build trust in the health data ecosystem.
Health & Life Sciences Addressing the Organ Donor Crisis Steps the federal government can take to end the organ transplant wait list.
Health & Life Sciences Creating the Health Advanced Research Projects Agency (HARPA) The federal government can directly address the massive market failures at the center of our healthcare enterprise by establishing a new Health Advanced Research Projects Agency.
